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PMyocardial Infarction/Ischemia
ew Risk Score for Patients With
cute Chest Pain, Non–ST-Segment
eviation, and Normal Troponin Concentrations
Comparison With the TIMI Risk Score
uan Sanchis, MD,* Vicent Bodí, MD,* Julio Núñez, MD,* Vicente Bertomeu-González, MD,*
ristina Gómez,* María José Bosch, MD,* Luciano Consuegra, MD,* Xavier Bosch, MD,†
rancisco J. Chorro, MD,* Àngel Llàcer, MD*
alència and Barcelona, Spain
OBJECTIVES The purpose of this research was to develop a risk score for patients with chest pain,
non–ST-segment deviation electrocardiogram (ECG), and normal troponin levels.
BACKGROUND Prognosis assessment in this population remains a challenge.
METHODS A total of 646 consecutive patients were evaluated by clinical history (risk factors and chest
pain score according to pain characteristics), ECG, and early exercise testing. ST-segment
deviation and troponin elevation were exclusion criteria. The primary end point was mortality
or myocardial infarction at one year. The secondary end point was mortality, myocardial
infarction, or urgent revascularization at 14 days (similar to the Thrombolysis In Myocardial
Infarction [TIMI] risk score).
RESULTS Primary and secondary end point rates were 6.7% and 5.4%. A risk score was constructed
using the variables related to the primary end point: chest pain score10 points (hazard ratio
[HR] 2.5; 1 point),2 pain episodes in last 24 h (HR 2.2; 1 point), age67 years (HR
 2.3; 1 point), insulin-dependent diabetes mellitus (HR  4.2; 2 points), and prior
percutaneous transluminal coronary angioplasty (HR  2.2; 1 point). Patients were classified
into five categories of risk (p 0.0001): 0 points, 0% event rate; 1 point, 3.1%; 2 points, 5.4%;
3 points, 17.6%; 4 points, 29.6%. The accuracy of the score was greater than that of the
TIMI risk score for the primary (C index of 0.78 vs. 0.66, p  0.0002) and secondary (C
index of 0.70 vs. 0.66, p  0.1) end points.
CONCLUSIONS Patients presenting with chest pain despite no ST-segment deviation or troponin elevation
show a non-negligible rate of events at one year. A risk score derived from this specific
population allows more accurate stratification than when using the TIMI risk score. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.037Coll Cardiol 2005;46:443–9) © 2005 by the American College of Cardiology Foundation
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ohe availability of troponin assay in emergency departments
as afforded substantial improvement in the diagnosis and
anagement of patients with non–ST-segment elevation
cute coronary syndrome (ACS). Troponin is a very sensi-
ive and specific marker of myocardial necrosis (1) and is
elpful as a guide to best management, including early
evascularization (2,3). The ST-segment depression in the
nitial electrocardiogram (ECG) is also helpful for identi-
ying patients with ACS at medium to high risk of events,
nd for guiding their management (4,5). In contrast to these
igh-risk markers, diagnosis and prognosis assessment in
atients with chest pain without ST-segment deviation or
roponin elevation remains a challenge. Though some data
uggested that a normal troponin result implies excellent
rognosis (6), other studies report a non-negligible 3% rate
f myocardial infarction or death at 30 days (7), which
From the *Servei de Cardiologia, Hospital Clínic Universitari, Universitat de
alència, València, Spain; and †Institut Clínic de Malalties Cardiovasculars. Hospital
línic, Barcelona, Spain. This work was supported by a grant from RECAVA-FIS.r
Manuscript received March 4, 2005; revised manuscript received March 29, 2005,
ccepted April 13, 2005.ncreased to 4.8% at six months of follow-up (8). Therefore,
areful risk stratification seems mandatory.
Several risk scores have been described for non–ST-
egment elevation ACS (9–13). The Thrombolysis In
yocardial Infarction (TIMI) risk score is the most widely
sed. Such scores derive from populations that include
igh-risk subsets (including ST-segment deviation and/or
ositive cardiac markers). Consequently, the applicability of
hese scores to lower-risk patients may not be adequate.
urthermore, troponin was not routinely used as marker of
ecrosis in most of these studies, and patients were not
anaged by a chest pain unit protocol, which seems to be
he most appropriate management for these lower-risk
atients (14).
The present study examined a series of patients with acute
hest pain without ST-segment deviation and presenting
ormal troponin concentrations. They were managed by a
hest pain unit protocol and were followed-up for one year.
risk score was elaborated using the predictors of poor
utcome, and its performance was compared to the TIMI
isk score.
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he study group consisted of 646 consecutive patients (from
anuary 15, 2001 to November 30, 2003) coming to the
mergency room with acute chest pain of possible coronary
rigin. ST-segment deviation (1-mm elevation or depres-
ion) in the initial ECG or troponin I elevation were
xclusion criteria. Troponin I was determined in our insti-
ution on arrival and at 6 h (in patients arriving within the
rst 2 h from pain onset), 8, and 12 h after pain onset
8,15,16). All patients had normal troponin concentrations
t all determinations.
Troponin I was determined immunologically using an
mmulite assay (Diagnostic Products Corp., Los Angeles,
alifornia). According to the instructions of the manufac-
urer, the Immulite troponin kit was used to test 255 serum
amples from healthy laboratory volunteers and from hos-
italized patients who had been shown to be negative for
roponin I by another immunometric method. The median
alues for these samples was non-detectable; 98% of the
alues were below 1.0 ng/ml. Troponin I increase was
efined as 1 ng/ml (upper limit of normality). The
roponin I assay was tested in our laboratory, the coefficient
f variation being 10%. Coefficients of variation were
btained at two levels: one within the normal range and the
ther above the normal range.
Patients were evaluated by a chest pain unit protocol that
ncluded evaluation of the clinical history and ECG, and
arly exercise testing in patients without contraindication to
xercise (physical incapacity or abnormalities in the baseline
CG) (8,12,13).
linical evaluation. The clinical characteristics of chest
ain presentation were assessed. On the basis of these
haracteristics, the semiquantitative score previously re-
orted by Geleijnse et al. (17) was calculated (Appendix). In
ddition, the following variables were recorded, including
hose variables collected in the TIMI risk score study (9):
ender, age, smoking, arterial hypertension, diabetes melli-
us, insulin-dependent diabetes mellitus (IDDM), hyper-
holesterolemia, family history of ischemic heart disease, at
east three risk factors for coronary artery disease, 2 chest
ain episodes in last 24 h, Killip class 1 at presentation,
vidence of prior coronary stenosis 50%, use of aspirin in
he last seven days, prior myocardial infarction, prior per-
Abbreviations and Acronyms
ACS  acute coronary syndrome
CABG coronary artery bypass graft
CI  confidence interval
HR  hazard ratio
IDDM insulin-dependent diabetes mellitus
PTCA  percutaneous transluminal coronary angioplasty
ROC  receiver-operating characteristic
TIMI  Thrombolysis In Myocardial Infarctionutaneous transluminal coronary angioplasty (PTCA), prior moronary artery bypass graft (CABG), and a history of heart
ailure. The TIMI risk score was calculated in all patients.
An ECG was recorded in the emergency room and
valuated for T-wave inversion (1 mm) or confounding
CG (left bundle branch block of paced rhythm).
arly exercise testing. A total of 322 patients (50%) were
ligible for early exercise testing (within the first 24 h after
rrival). A symptom-limited Bruce protocol was used. The
esult was considered positive in the case of ischemia
nduction (indicated by a 1-mm horizontal or downsloping
epression of the ST-segment at 80 ms from the J point, or
1-mm ST-segment elevation). A negative test was con-
idered when at least a submaximal test was performed
ithout ST-segment changes. An inconclusive test was
onsidered if the patient was unable to reach submaximal
eart rate (85% of the theoretical-age-predicted heart rate)
ithout ischemia. All 190 patients with a negative result
ere discharged after the exercise test, while all 52 with a
ositive test were hospitalized. In the case of an inconclusive
est, the final decision was left to the criterion of the
upervising physician.
n-hospital management. Overall, 216 patients were early
ischarged and 430 hospitalized. All hospitalized patients
ere treated with aspirin, low-molecular-weight heparin,
nd beta-blockers (unless contraindicated). Patients under-
ent invasive management in case of recurrent chest pain or
vidence of ischemia in noninvasive tests. Cardiac catheter-
zation was performed in 227 patients (35% of the global
opulation and 53% of the hospitalized patients). During
ospitalization 68 patients underwent PTCA and 31
ABG. Creatine kinase-MB mass (5 ng/ml upper limit of
ormal) was routinely determined 12 and 24 h after a
evascularization procedure. Fifty-seven patients had nor-
al coronary arteries.
nd points. Patients were followed-up for one year. Com-
lete follow-up was obtained in 98% of the patients (a total
f 11 cases were missed). The end points considered in the
IMI risk score study were used in the present study (9).
herefore all-cause mortality, acute myocardial infarction,
nd urgent revascularization were recorded. An acute myo-
ardial infarction was defined as a new episode of chest pain
ith increased troponin I. Acute myocardial infarction was
lso considered if creatine kinase-MB mass increased to 3
imes the upper limit of normal after PTCA or to 5 times
he upper limit of normal after coronary bypass surgery.
evere recurrent ischemia requiring urgent revascularization
as defined as an episode of recurrent angina prompting the
erformance of coronary revascularization on the index
ospitalization or an episode of recurrent angina after
ischarge that resulted in re-hospitalization during which
oronary revascularization was performed.
The primary end point was a composite of all-cause
ortality or non-fatal myocardial infarction at one year.
he secondary end point was a composite of all-cause
ortality, non-fatal myocardial infarction, or urgent revas-
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August 2, 2005:443–9 Risk Score for Patients With Chest Painularization at 14 days (similar to the primary end point of
he TIMI risk score study).
tatistical analysis. To analyze the predictors for the end
oints, data from the clinical history were taken as inde-
endent variables. Continuous variables were expressed as
he mean  SD and compared by the unpaired t test or the
nalysis of variance test for more than two groups. Cate-
orical variables were expressed as percentages and com-
ared by the chi-square test. Continuous variables, such as
ge and chest pain score, were dichotomized, taking the best
utoff point of the receiver-operating characteristic (ROC)
urves for primary end point prediction. Multivariate anal-
sis by Cox regression models tested variables that were
ignificant at p  0.1 in the univariate analysis. The hazard
atios (HRs) and their 95% confidence intervals (CIs) were
alculated. A risk score was developed using the five
ariables associated with the primary end point in the
ultivariable analysis. For the construction of the risk score,
ach variable was considered as 1 point except IDDM,
hich was considered as 2 points because its HR was twice
he value of the HR of the remaining variables. The ROC
urves were used to test the accuracy of the new risk score
nd of the TIMI risk score for predicting the primary and
econdary end points. The ROC curves corresponding to
oth risk scores were compared.
Calculations were performed using the SPSS software
ersion 9.0 (SPSS Inc., Chicago, Illinois). Comparison
etween ROC curves was performed using the STATA
oftware version 8.2 (Stata Corp., College Station, Texas).
tatistical significance was considered for p  0.05.
alidation cohort. The new risk score was validated in a
econd cohort comprising 171 consecutive patients coming
o the emergency room of our hospital with acute chest pain
ithout ST-segment deviation and with normal troponin
evels, in the period immediately after the inclusion of the
rst cohort (from December 1, 2003 to February 1, 2005).
he primary end point (death or myocardial infarction) was
ecorded for a median follow-up of 28 weeks.
ESULTS
atient population characteristics. Table 1 shows the
linical and ECG characteristics of the global patient
opulation.
During one year of follow-up, 21 patients died (3.3%)
nd 29 suffered acute myocardial infarction (4.5%). Two
eaths and six infarctions were related to revascularization
rocedures. The primary end point (death or myocardial
nfarction) occurred in 43 patients (6.7%). At 14 days of
ollow-up, 5 patients died (0.8%), 17 suffered acute myo-
ardial infarction (2.6%), 26 underwent urgent revascular-
zation (4%), and 35 (5.4%) reached the secondary end point
death, myocardial infarction, or urgent revascularization).
redictors of the primary end point. Table 2 lists the
redictors of the primary end point by univariate and
ultivariate analysis. Chest pain score (11.6 2.4 points vs. I0.3 2.8 points, p 0.002) and age (70 11 years vs. 64
12 years, p  0.001) were associated with the primary
nd point. According to their ROC curves, these variables
ere dichotomized as 10 points and 67 years, respec-
ively, for predictive analysis.
In order to evaluate the influence of early exercise testing,
he patient population was divided into four groups accord-
ng to the performance and results of the exercise test as
ollows: negative result, inconclusive result, positive result,
nd not performed. The rates of the primary end point were
.6%, 3.9%, 9.6%, and 10%, respectively (p  0.002 for the
rend), significance being reached for the differences be-
ween the subgroup with a negative result and the subgroup
ith inability to perform the test (p  0.004). Thus, a
egative result in the early exercise test and inability to
erform the test were incorporated to the predictive analysis
s independent variables (Table 2).
By multivariable Cox regression analysis, the independent
actors that increased the risk of the primary end point were
chest pain score 10 points (HR  2.5, 95% CI 1.2 to
.6, p  0.02), 2 chest pain episodes in last 24 h (HR 
.2, 95% CI 1.2 to 4.2, p  0.01), age 67 years (HR 
.3, 95% CI 1.2 to 4.4, p  0.01), IDDM (HR  4.2, 95%
I 2.1 to 8.4, p  0.0001), and prior PTCA (HR  2.2,
5% CI 1.1 to 4.8, p  0.04).
isk score. A risk score was constructed taking the five
ariables independently related to the primary end point. To
his effect, 1 point value was assigned to those variables
aving a similar HR, as chest pain score 10 points, 2
hest pain episodes in the last 24 h, age67 years, and prior
TCA. On the other hand, a 2-point value was used for
able 1. Characteristics of the Patient Population (n  646)
linical history
Chest pain score (points) 10.4  2.8
2 chest pain episodes in last 24 h 229 (35%)
Killip class 1 20 (3%)
Age (yrs) 64  12
Men 425 (68%)
Current smokers 131 (20%)
Hypertension 380 (59%)
Hypercholesterolemia 341 (53%)
Diabetes mellitus 166 (26%)
IDDM 45 (7%)
Family history of ischemic heart disease 78 (12%)
At least three risk factors* 81 (13%)
Prior coronary stenosis 50% 156 (24%)
Use of aspirin in last 7 days 278 (43%)
Prior myocardial infarction 163 (25%)
Prior PTCA 59 (9%)
Prior CABG 50 (8%)
History of heart failure 13 (2%)
CG
T-wave inversion 66 (10%)
Confounding ECG 56 (9%)
Risk factors included family history of ischemic heart disease, hypertension, hyper-
holesterolemia, diabetes, or being a current smoker.
CABG  coronary artery bypass grafting; ECG  electrocardiogram; IDDM 
nsulin-dependent diabetes mellitus; PTCA  percutaneous transluminal coronary
ngioplasty.DDM because its HR was two-fold greater. The variables
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Risk Score for Patients With Chest Pain August 2, 2005:443–9f the stress test were not included in the final score because
hey were not significant in the Cox regression analysis.
istribution of the patient population according to the risk
core was as follows: 0 points, n  111 (17.2%); 1 point, n
198 (30.7%); 2 points, n  206 (31.9%); 3 points, n 
03 (15.9%); 4 points, n  16 (2.5%); 5 points, n  11
1.7%); and 6 points, n  1 (0.2%). Because of the small
umber of patients in the extreme upper score range,
atients with 4 to 6 points were combined (n  28, 4.3%).
ive categories were therefore distinguished (Fig. 1): very
ow-risk (0 points, primary end point  0%), low-risk (1
oint, primary end point  3.1%), intermediate-risk (2
oints, primary end point  5.4%), high-risk (3 points,
rimary end point 17.6%), and very high-risk (4 points,
rimary end point  29.6%). The statistical significance for
he trend was p 0.00001, the differences between the very
ow-, low- and intermediate-risk categories being significant
ompared with the very high- (p 0.0001, p 0.0001, and
 0.0001, respectively) and high-risk (p  0.002, p 
.0001, p  0.0001, respectively) categories.
omparison with the TIMI risk score. The accuracy of
he new risk score for the primary end point was tested by
ROC curve, showing a C index of 0.78 (p 0.0001). The
IMI risk score was also associated with the primary end
oint (C index of 0.66, p  0.0001). However, the C index
f the new risk score was significantly greater (p  0.0002,
ig. 2). The accuracy of both risk scores was also tested for
he secondary end point consisting of death, myocardial
Table 2. Predictors of the Primary End Point
U
Clinical history
Pain score 10 points
2 chest pain episodes in last 24 h
Killip 1
Age 67
Men
Current smokers
Hypertension
Hypercholesterolemia
Diabetes mellitus
IDDM
Family history of ischemic heart disease
At least three risk factors
Prior coronary stenosis 50%
Use of aspirin in last 7 days
Prior myocardial infarction
Prior PTCA
Prior CABG
History of heart failure
ECG
T-wave inversion
Confounding ECG
Early exercise test
Negative result
Inability to exercise
CI  confidence interval; HR  hazard ratio; other abbrevinfarction, or urgent revascularization at 14 days, for which
i
cigure 1. Risk categories according to risk score: very low-risk (0 points,
rimary end point  0%), low-risk (1 point, primary end point  3.1%),
ntermediate-risk (2 points, primary end point  5.4%), high-risk (3
oints, primary end point  17.6%), and very high-risk (4 points,
rimary end point  29.6%). The statistical significance for the trend was
 0.00001; the differences between the very low-, low-, and
ntermediate-risk categories being significant compared to the very high- (p
0.0001, p  0.0001, and p  0.0001, respectively) and high-risk (p 
.002, p  0.0001, p  0.0001, respectively) categories. IDDM (Death or Myocardial Infarction)
nivariate Multivariate
p Value p Value HR 95% CI
0.001 0.02 2.5 1.2–5.6
0.001 0.01 2.2 1.2–4.2
0.1 0.7
0.004 0.01 2.3 1.2–4.4
0.4
0.2
0.4
0.6
0.001 0.2
0.0001 0.0001 4.2 2.1–8.4
0.6
0.8
0.1 0.7
0.02 0.6
0.1 0.9
0.05 0.04 2.2 1.1–4.8
0.1 0.8
0.6
0.4
0.09 0.3
0.0001 0.07
0.001 0.2nsulin-dependent diabetes mellitus; PTCA  percutaneous transluminal
oronary angioplasty.
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August 2, 2005:443–9 Risk Score for Patients With Chest Painhe TIMI risk score was originally designed (9). The new
isk score (C index of 0.70, p  0.0001) and the TIMI risk
core (C index of 0.66, p  0.002) were both correlated to
he secondary end point, but without significant differences
etween them (p  0.1).
alidation cohort. In the validation cohort the primary
nd point occurred in eight patients (4.7%). The new risk
core was associated with the primary end point (C index of
.78, p 0.007) and was more accurate (p 0.05) than the
IMI risk score (C index of 0.70, p  0.06).
ISCUSSION
ain findings. The present study included a series of
atients presenting to the emergency department with acute
hest pain, non–ST-segment deviation in the initial ECG,
nd normal troponin concentrations. After one year of
ollow-up, a 6.7% rate of mortality or nonfatal myocardial
nfarction was found. Clinical data at presentation allowed
isk stratification. Using clinical predictors, a risk score
roved to be useful for prognostic categorization. This new
isk score evidenced superior accuracy than the TIMI risk
core for this specific population.
rognosis of patients with chest pain and normal tropo-
in levels. The introduction of troponin as a diagnostic
ool facilitates the triage of patients with acute chest pain.
owever, though a negative troponin result identifies a
ower risk, this does not necessarily imply a low-risk group
18). Although initial studies reported an excellent short-
erm prognosis for troponin-negative patients (6), later data
ound a non-negligible 3% rate of major events at 30 days
7) and 4.8% at 6 months (8). In the present study, in which
T-segment deviation in the initial ECG was an exclusion
riterion, the rate of death or myocardial infarction was
igure 2. Receiver-operating characteristic curves of the new risk score and
nd point (death or myocardial infarction at 1 year) (left) and the secondary
right). The accuracy of the new risk score was greater for both the primary
 0.1) end points. Solid line  new risk score; dashed line  TIMI r.7% at one year. For a longer period of follow-up, a 10% rvent rate has been observed at 31 months (19). These data,
herefore, point to the need for careful prognostic assess-
ent in this population despite its apparent low risk.
isk score. Evaluation of the clinical history in the emer-
ency room is of utmost importance in patients with chest
ain, mainly in the absence of other objective signs as is the
ase of a non–ST-segment deviation ECG and negative
arkers of necrosis. In the present study, a risk score was
onstructed with five clinical variables of the clinical history
hat were shown to have important prognostic value: typical
resentation of chest pain (evaluated by a chest pain score);
wo or more chest pain episodes in the last 24 h; a patient
ge of 67 years or older; IDDM; and prior PTCA. This
core was useful for patient classification into five progres-
ive risk categories (0%, 3.1%, 5.4%, 17.6%, and 29.6%
vent rate).
One of the major problems with chest pain symptoms is
hat they are variable and perceived very differently by
atients (20). In order to define the characteristics of chest
ain, we used a chest pain score previously published by
eleijnse et al. (17) that has been shown to possess
rognostic value in a previous series of patients with chest
ain and negative troponin levels with or without ST-
egment depression in the initial ECG (8). The chest pain
core was associated with poorer outcome, reflecting that a
ypical presentation increases the probability of a cardiac
rigin of the pain. Recurrence of chest pain within 24 h
efore admission increased the risk as a marker of instabil-
ty. Older age was another predictor of risk, as seen in all
isk scores for non–ST-segment ACS (9–12). Diabetes
ellitus was an independent factor in the univariate analy-
is, though, in the multivariate model, IDDM was the
ariable included, its HR being twice the value of the
Thrombolysis In Myocardial Infarction (TIMI) risk score for the primary
oint (death or myocardial infarction or urgent revascularization at 14 days)
dex of 0.78 vs. 0.66, p  0.0002) and secondary (C index of 0.70 vs. 0.66,
ore.of the
end pemaining factors. The longer evolution of their metabolic
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Risk Score for Patients With Chest Pain August 2, 2005:443–9isturbance as well as the more diffuse coronary disease and
maller arterial size observed in diabetics treated with
nsulin could explain this finding (21). Finally, a previous
TCA as hallmark of a documented history of coronary
rtery disease requiring revascularization also exerted prog-
ostic influence.
omparison to the TIMI risk score. Among the risk
cores described for non–ST-segment elevation ACS, the
IMI risk score is the most widely used (9). Although it was
ot designed for the whole spectrum of patients with acute
hest pain, its use tended to be generalized in all patients
ith non–ST-segment elevation chest pain. The present
tudy demonstrates that the new risk score is more accurate
han the TIMI risk score in patients with non–ST-segment
eviation ECG and normal troponin values, especially for
redicting major events at one year. Its predictive accuracy
or short-term cardiac events for which the TIMI risk score
as originally calculated was similar. The main explanation
or this could be that the TIMI risk score was not designed
or such a low-risk population. The TIMI risk score was
esigned to facilitate risk stratification in patients with
on–ST-segment elevation ACS. It was not designed to aid
n the diagnosis of this syndrome, which continues to be
ased on clinical parameters that may be supported by
ppropriate ECG changes or elevations of biomarkers of
ecrosis. In addition, the characteristics of chest pain
resentation were not evaluated in the TIMI risk score,
robably because of their lesser role in high-risk patients.
inally, diabetes and IDDM were not tested as individual
isk factors.
tudy limitations. The risk score was verified on a separate
alidation cohort. However, this validation cohort examined
he primary end point after a median follow-up of 28 weeks,
s opposed to the primary end point in the original cohort
hat examined outcome after 52 weeks.
onclusions. In patients presenting with acute chest
ain, the presence or absence of ST-segment deviation or
roponin elevation differentiates a high- from a low-risk
roup of patients. The latter patients, however, show a
on-negligible 6.7% rate of major events at one year.
linical variables at presentation, such as typical charac-
eristics of the chest pain, two or more chest pain
pisodes in the last 24 h, patient age 67 years or older,
DDM, and prior PTCA, allow the construction of a risk
core that has been shown to be useful for early prognos-
ic stratification. The predictive accuracy of this score for
ne-year major cardiac events is greater than that of the
IMI risk score.
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hest Pain Score (Geleijnse et al. [17])
ocation
Substernal 3
Precordial 2
Neck, jaw, epigastrium 1
Apical 1
adiation
Either arm 2
Shoulder, back, neck, jaw 1
haracteristics
Crushing, pressing, squeezing 3
Heaviness, tightness 2
Sticking, stabbing, pinprick, catching 1
everity
Severe 2
Moderate 1
nfluenced by
Nitroglycerin 1
Stature 1
Breathing 1
ssociated symptoms
Dyspnea 2
Nausea or vomiting 2
Diaphoresis 2
istory of exertional angina 3
